case_images: PMC10629335_01
case_images: Brain magnetic resonance imaging shows a sellarsuprasellar lesion, (a) isointense to hypointense on T1 and (b) isointense to hyperintense on T2.
case_images: SNI-14-379-g001.jpg
case_images: PMC10629335_01_SNI-14-379-g001.jpg
case_images: F1
case_images: Magnetic resonance imaging (MRI) of the brain shows a sellar-suprasellar lesion, isointense to hypointense on T1, isointense to hyperintense on T2 [Figure 1], enhanced heterogeneously with gadolinium [Figures 2a and b], with other small lesions in the posterior cerebral fossa and the hypothalamus.
case_images: Brain magnetic resonance imaging shows a sellarsuprasellar lesion, (a and b) heterogeneous enhancement with gadolinium is observed on the T1 sequence. (c and d) The lesions exhibit complete resolution following treatment.
case_images: SNI-14-379-g002.jpg
case_images: PMC10629335_01_SNI-14-379-g002.jpg
case_images: F2
case_images: Magnetic resonance imaging (MRI) of the brain shows a sellar-suprasellar lesion, isointense to hypointense on T1, isointense to hyperintense on T2 [Figure 1], enhanced heterogeneously with gadolinium [Figures 2a and b], with other small lesions in the posterior cerebral fossa and the hypothalamus. Treatment for tuberculosis was initiated with a 2-month combination of isoniazid, rifampicin, pyrazinamide, and ethambutol, followed by 7 months of isoniazid and rifampicin, associated with corticosteroid therapy, and the evolution was marked by the clinical improvement of the patient, even on the radiological level, by the disappearance of the lesion [Figures 2c and d].